Update shared on12 Oct 2025
Fair value Increased 1.63%Analysts have raised their price target for Nippon Life India Asset Management from ₹871.15 to ₹885.33. They cite improved profit margin forecasts, which offset slightly lower revenue growth expectations.
What's in the News
- A scheduled Board Meeting will be held on October 30, 2025, to consider and approve the unaudited financial results for the quarter and half year ending September 30, 2025 (Key Developments).
- The Board will also discuss the possible declaration of an interim dividend during this meeting (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has risen slightly from ₹871.15 to ₹885.33, reflecting adjustments in company outlook.
- Discount Rate increased modestly from 14.65% to 14.76%, indicating a marginally higher perceived risk.
- Revenue Growth expectations have fallen from 14.17% to 13.49%, suggesting slightly slower top-line expansion.
- Net Profit Margin forecast improved from 52.68% to 53.78%, pointing to expectations of greater profitability.
- Future P/E ratio climbed from 40.63x to 41.30x, signaling a small uptick in anticipated earnings valuation.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.